Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03003715 · ClinicalTrials.gov registry record · NA
Brain as a Therapeutic and Research Target in Trigeminal Neuropathic Pain
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT03003715: Completed NA study, sponsored by University of Michigan.
NCT03003715 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03003715, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The main goal of this study to integrate techniques producing images of the brain (also called neuroimaging techniques) with non-invasive brain stimulation to investigate factors that may be associated with chronic pain in patients with Trigeminal Neuropathic Pain (TNP).
Primary Outcome
change from baseline to versus sham or active tDCS
Interventions
- PROCEDURE MRI
- PROCEDURE PET Scans
- PROCEDURE transcranial direct current stimulation (tDCS)
- OTHER sham tDCS (prior to real tDCS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2011-09 |
| Est. Completion | 2012-12 |
| Phase | NA |
What the finished NCT03003715 record still lists
NCT03003715 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which MRI is the first listed.
NCT03003715 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03003715 about?
NCT03003715 is a clinical study titled "Brain as a Therapeutic and Research Target in Trigeminal Neuropathic Pain". The main goal of this study to integrate techniques producing images of the brain (also called neuroimaging techniques) with non-invasive brain stimulation to investigate factors that may be associated with chronic pain in patients with Trigeminal Neuropathic Pain (TNP).
What is the current status of trial NCT03003715?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2011-09. Estimated completion is 2012-12.
What interventions are being tested in trial NCT03003715?
The interventions under investigation include: MRI (PROCEDURE), PET Scans (PROCEDURE), transcranial direct current stimulation (tDCS) (PROCEDURE), sham tDCS (prior to real tDCS) (OTHER).
Who is sponsoring clinical trial NCT03003715?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03003715's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia